Activated Vγ9Vδ2 T Cells Trigger Granulocyte Functions via MCP-2 Release

被引:35
作者
Agrati, Chiara [1 ]
Cimini, Eleonora [1 ]
Sacchi, Alessandra [1 ]
Bordoni, Veronica [1 ]
Gioia, Cristiana [1 ]
Casetti, Rita [1 ]
Turchi, Federica [1 ]
Tripodi, Marco [1 ]
Martini, Federico [1 ]
机构
[1] Natl Inst Infect Dis Lazzaro Spallanzani, IRCCS, Rome, Italy
关键词
NONPEPTIDE ANTIGENS; MYCOBACTERIUM-TUBERCULOSIS; ANTIVIRAL IMMUNITY; ZOLEDRONIC ACID; CC CHEMOKINES; IN-VITRO; INFECTION; DEFENSINS; STIMULATION; LYMPHOCYTES;
D O I
10.4049/jimmunol.182.1.522
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
V gamma 9V delta 2 T cells display a broad antimicrobial activity by directly killing infected cells and by inducing an effective adaptive immune response. The activation of V gamma 9V delta 2 T cells by aminobisphosphonate drugs such as zoledronic acid (ZOL) results in a massive release of cytokines and chemokines that may induce a bystander activation of other immune cells. The aim of this work was to evaluate the ability of soluble factors released by ZOL-activated V gamma 9V delta 2 T cells to induce granulocyte activation. We showed that soluble factors released by ZOL-stimulated V gamma 9V delta 2 T cells activate granulocytes by inducing their chemotaxis, phagocytosis, and alpha-defensins release. Proteomic analysis allowed us to identify a number of cytokines and chemokines specifically released by activated V gamma 9V delta 2 T cells. Moreover, MCP-2 depletion by neutralizing Ab revealed a critical role of this chemokine in induction of granulocyte alpha-defensins release. Altogether, these data show a V gamma 9V delta 2-mediated activation of granulocytes through a bystander mechanism, and confirm the wide ability of V gamma 9V delta 2 T-lymphocytes in orchestrating the immune response. In conclusion, an immune modulating strategy targeting V gamma 9V delta 2 T cells may represent a key switch to induce an effective and well-coordinated immune response, and can be proposed as a way to strengthen the immune competence during infectious diseases. The Journal of Immunology, 2009, 182: 522-529.
引用
收藏
页码:522 / 529
页数:8
相关论文
共 50 条
  • [21] Antigen-presenting effects of effector memory Vγ9Vδ2 T cells in rheumatoid arthritis
    Hu, Chaoying
    Qian, Liu
    Miao, Yi
    Huang, Qiuyu
    Miao, Ping
    Wang, Ping
    Yu, Qiwen
    Nie, Hong
    Zhang, Jiying
    He, Dongyi
    Xu, Rong
    Chen, Xuehua
    Liu, Bingya
    Zhang, Dongqing
    CELLULAR & MOLECULAR IMMUNOLOGY, 2012, 9 (03) : 245 - 254
  • [22] Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection
    Soriano-Sarabia, Natalia
    Archin, Nancie M.
    Bateson, Rosalie
    Dahl, Noelle P.
    Crooks, Amanda M.
    Kuruc, JoAnn D.
    Garrido, Carolina
    Margolis, David M.
    PLOS PATHOGENS, 2015, 11 (10)
  • [23] Functional Phenotypes of Human Vγ9Vδ2 T Cells in Lymphoid Stress Surveillance
    Nussbaumer, Oliver
    Thurnher, Martin
    CELLS, 2020, 9 (03)
  • [24] Early Triggering of Exclusive IFN-γ Responses of Human Vγ9Vδ2 T Cells by TLR-Activated Myeloid and Plasmacytoid Dendritic Cells
    Devilder, Marie-Claire
    Allain, Sophie
    Dousset, Christelle
    Bonneville, Marc
    Scotet, Emmanuel
    JOURNAL OF IMMUNOLOGY, 2009, 183 (06) : 3625 - 3633
  • [25] The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells
    Castella, Barbara
    Kopecka, Joanna
    Sciancalepore, Patrizia
    Mandili, Giorgia
    Foglietta, Myriam
    Mitro, Nico
    Caruso, Donatella
    Novelli, Francesco
    Riganti, Chiara
    Massaia, Massimo
    NATURE COMMUNICATIONS, 2017, 8
  • [26] Vγ9Vδ2 T cells and zoledronate mediate antitumor activity in an orthotopic mouse model of human chondrosarcoma
    Sun, L.
    Li, Y.
    Jiang, Z.
    Zhang, J.
    Li, H.
    Li, B.
    Ye, Z.
    TUMOR BIOLOGY, 2016, 37 (06) : 7333 - 7344
  • [27] Development and Selection of the Human Vγ9Vδ2+ T-Cell Repertoire
    Willcox, Carrie R.
    Davey, Martin S.
    Willcox, Benjamin E.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [28] Directing the migration of serum-free, ex vivo-expanded Vγ9Vδ2 T cells
    Parwani, Kiran K.
    Branella, Gianna M.
    Burnham, Rebecca E.
    Burnham, Andre J.
    Bustamante, Austre Y. Schiaffino
    Foppiani, Elisabetta Manuela
    Knight, Kristopher A.
    Petrich, Brian G.
    Horwitz, Edwin M.
    Doering, Christopher B.
    Spencer, H. Trent
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [29] Improving the Efficiency of Vγ9Vδ2 T Cell Immunotherapy in Cancer
    Hoeres, Timm
    Smetak, Manfred
    Pretscher, Dominik
    Wilhelm, Martin
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [30] Phenotypic and functional characterization of pharmacologically expanded Vγ9Vδ2 T cells in pigtail macaques
    Barber-Axthelm, Isaac M.
    Wragg, Kathleen M.
    Esterbauer, Robyn
    Amarasena, Thakshila H.
    Barber-Axthelm, Valerie R. B.
    Wheatley, Adam K.
    Gibbon, Anne M.
    Kent, Stephen J.
    Juno, Jennifer A.
    ISCIENCE, 2023, 26 (03)